Assembly Biosciences
ASMB
62 hedge funds and large institutions have $53.8M invested in Assembly Biosciences in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 12 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.19% less ownership
Funds ownership: 4.21% → 4.02% (-0.19%)
5% less funds holding
Funds holding: 65 → 62 (-3)
24% less call options, than puts
Call options by funds: $68K | Put options by funds: $89K
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
32% less capital invested
Capital invested by funds: $78.8M → $53.8M (-$25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.48M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.01M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$823K |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$701K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$615K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$5.22M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.24M |
| 4 |
BlackRock
New York
|
-$2.14M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$924K |
ASMB Hedge Fund Activity: Q4 2021 in Review
62 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2021, worth a combined $53.8M — down 32% from $78.8M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ASMB and 9 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 21 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.48M. The largest seller was Boxer Capital, exiting entirely with an estimated $5.22M sold.
- 62 institutional investors held Assembly Biosciences (ASMB) as of Q4 2021, down from 65 in Q3 2021.
- Funds reported $53.8M of Assembly Biosciences stock for Q4 2021, down 32% quarter-over-quarter.
- 9 funds opened new Assembly Biosciences positions in Q4 2021 and 12 closed out, a net change of -3 holders.
- The largest Assembly Biosciences buyer in Q4 2021 was Renaissance Technologies, an estimated $1.48M added.
- The largest Assembly Biosciences seller in Q4 2021 was Boxer Capital, an estimated $5.22M sold.
Based on aggregated 13F filings for Q4 2021.